TVM Capital Healthcare, a healthcare private equity firm dual-headquartered in Singapore and Dubai, has injected 10 million euros ($10.8 million) into Amsterdam-based medtech company DEBx Medical, per a company announcement on Monday. 

DEBx Medical will use the funding to expand its global footprint and establish a regional headquarter and a production base in the MENA region, according to the statement.

The Dutch medtech company offers diagnosis through treatment and follow-up care of patients suffering from non-healing chronic wounds. 

The investment is through the firm’s TVM Healthcare Afiyah Fund. One of the fund’s limited partners (LPs) is the Saudi Venture Fund, which invested $10 million in the vehicle late last year.

TVM Capital Healthcare, the UAE arm of German investment firm TVM Capital, focuses on growth capital investments in emerging markets and invests in healthcare manufacturing companies or tech-enabled healthcare services and digital health solutions and platforms. It has offices across Singapore, Dubai, Riyadh, Boston, Munich, and Ho Chi Minh City. 

The PE firm is looking at investing in non-hospital assets in Southeast Asia through a market-focused fund, which is expected to make a first close by 1H 2023, a top executive at the firm told DealStreetAsia last December. 

Last June, TVM Capital Healthcare participated in Singapore biotech startup AMILI’s $10.5-million Series A funding round anchored by the investment arm of the late Microsoft co-founder Paul Allen.